Intech Biopharm Stock

Intech Biopharm Net Margin

The Net Profit Margin of Intech Biopharm (6461.TWO) as of Jul 24, 2026 is -925.63 %. In the previous year, Net Profit Margin was -1,307.64 % — a change of -29.21% (higher).

Net Margin

-925.63 %

YoY

-29.21%

Last updated:

Net Profit Margin of Intech Biopharm is 2026 -925.63 % . Net Profit Margin of Intech Biopharm was 2025 -1,307.64 % . It decreases by -29.21% higher compared to the previous year.

For Intech Biopharm, the net margin of -925.6% is up versus -1,186.3% a few years ago.

Access this data via the Eulerpool API

Intech Biopharm Stock analysis

What does Intech Biopharm do? Intech Biopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intech Biopharm stock

Net Profit Margin of Intech Biopharm is -925.63 % in 2026.

Access this data via the Eulerpool API

Margins — Intech Biopharm

All Key Metrics — Intech Biopharm